DAPSONE-INDUCED HEMATOLOGIC TOXICITY - COMPARISON OF THE METHEMOGLOBIN-FORMING ABILITY OF HYDROXYLAMINE METABOLITES OF DAPSONE IN RAT AND HUMAN BLOOD

被引:28
作者
VAGE, C [1 ]
SAAB, N [1 ]
WOSTER, PM [1 ]
SVENSSON, CK [1 ]
机构
[1] WAYNE STATE UNIV,COLL PHARM & ALLIED HLTH PROFESS,DEPT PHARMACEUT SCI,DETROIT,MI 48202
关键词
D O I
10.1006/taap.1994.1255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The relative methemoglobin (MetHgb) forming ability of two metabolites of dapsone, dapsone hydroxylamine (DDS-NOH) and monoacetyldapsone hydroxylamine (MADDS-NOH), were compared in rat and human whole blood. Concentration-response curves for the two metabolites were generated in vitro in whole blood. Data were fit to both the E(max) and Sigmoid E(max) models. The E(max) values for MetHgb formation in rat blood for MADDS-NOH and DDS-NOH fitted to the E(max) model were 83 (8) and 84 (2)%, while the EC(50) values were 1087 (283) and 828 (104) mu M, respectively (mean +/- SD). Neither these values nor those generated for the Sigmoid E(max) model differed significantly between the two metabolites. Similarly, the E(max) values in human blood for MADDS-NOH and DDS-NOH fitted to the E(max) model were 79 (5) and 80 (2)%; while the EC(50) values were 90 (17) and 95 (19) mu M, respectively. These values also did not differ between the two metabolites using either pharmacodynamic model. MetHgb was produced at the same rate, reached similar peak concentrations, and exhibited the same rate of decline with both metabolites. The area under the MetHgb content versus time curve did not differ between the two metabolites. These data demonstrate that MADDS-NOH and DDS-NOH are equipotent and equally efficacious in their MetHgb-forming ability. Investigation of the disposition of these metabolites is necessary to assess their relative role in dapsone-induced toxicity in vivo. (C) 1994 Academic Press,Inc.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 18 条
[1]   ASCORBIC-ACID AND CHEMICALLY INDUCED METHEMOGLOBINEMIAS [J].
BOLYAI, JZ ;
SMITH, RP ;
GRAY, CT .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 21 (02) :176-+
[2]   THE USE OF CIMETIDINE AS A SELECTIVE INHIBITOR OF DAPSONE N-HYDROXYLATION IN MAN [J].
COLEMAN, MD ;
SCOTT, AK ;
BRECKENRIDGE, AM ;
PARK, BK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) :761-767
[3]   USE OF A METABOLIC INHIBITOR TO REDUCE DAPSONE-DEPENDENT HEMATOLOGICAL TOXICITY [J].
COLEMAN, MD ;
TINGLE, MD .
DRUG DEVELOPMENT RESEARCH, 1992, 25 (01) :1-16
[4]   AN INVESTIGATION INTO THE HEMATOLOGICAL TOXICITY OF STRUCTURAL ANALOGS OF DAPSONE INVIVO AND INVITRO [J].
COLEMAN, MD ;
TINGLE, MD ;
HUSSAIN, F ;
STORR, RC ;
PARK, BK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (11) :779-784
[5]   INHIBITION OF DAPSONE-INDUCED METHEMOGLOBINEMIA IN THE RAT [J].
COLEMAN, MD ;
WINN, MJ ;
BRECKENRIDGE, AM ;
PARK, BK .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (04) :802-805
[6]   BIOACTIVATION OF DAPSONE TO A CYTO-TOXIC METABOLITE BY HUMAN HEPATIC-MICROSOMAL ENZYMES [J].
COLEMAN, MD ;
BRECKENRIDGE, AM ;
PARK, BK .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (04) :389-395
[7]   REDUCTION OF DAPSONE HYDROXYLAMINE TO DAPSONE DURING METHEMOGLOBIN FORMATION IN HUMAN ERYTHROCYTES INVITRO [J].
COLEMAN, MD ;
JACOBUS, DP .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (05) :1027-1033
[8]   SEX-DEPENDENT SENSITIVITY TO DAPSONE-INDUCED METHEMOGLOBINEMIA IN THE RAT [J].
COLEMAN, MD ;
WINN, MJ ;
BRECKENRIDGE, AM ;
PARK, BK .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (04) :805-809
[9]   MICROSOMAL N-OXIDATION OF DAPSONE AS A CAUSE OF METHEMOGLOBIN FORMATION IN HUMAN RED-CELLS [J].
CUCINELL, SA ;
DAYTON, PG ;
ISRAILI, ZH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1972, 21 (03) :322-+
[10]  
GABEL O, 1940, CHEM ABST, V34, P6244